Skip to content

Adis in touch

A blog from Adis, a leading global provider of drug information.

Search for:

Recent Posts

Safety strategies and efficiencies – what is the best solution?
Brexanolone (Zulresso™): First Global Approval – First approved therapy for postpartum depression
Artificial Intelligence: organised chaos or chaos ordered?
Is the Search for a Cure for Alzheimer’s Disease Hopeless?
DIA India 2019: Regulatory Trends in Clinical Safety & Pharmacovigilance (An EU perspective).

Recent Comments

	Dr Paul Tappenden as… on Call for Papers: Themed Issue…
	Dupilumab (Dupixent®… on Dupilumab (Dupixent®): First G…
	Durvalumab (IMFENZI®… on Durvalumab (IMFINZI®): Follow…
	Dupilumab (Dupixent®… on Dupilumab (Dupixent®): First G…
	Baricitinib (Olumian… on Baricitinib (Olumiant™): First…

Archives

Categories

Adis (88)
Adis Journals (94)
Adis Pharmacovigilance (29)
AdisInsight (96)
Uncategorized (2)

July 5, 2017 2551 × 1914

2.Co-editorsofnewacademicbook

Leave a Reply Cancel reply

Powered by WordPress.com.